Congrats to Robert H. Vonderheide, MD, DPhil, Director of the Abramson Cancer Center on receiving the 2025 Jill Rose Award—BCRF’s highest scientific honor! His pioneering work in cancer interception and immunotherapy is shaping the future of breast cancer care. https://bit.ly/3JT8QzB

Three weeks to go!⏳Register for the Immune Health Hackathon (Nov. 20–21). Join the Penn community for 48 hours of collaboration and discovery as teams tackle real-world challenges in immunology research. Don’t miss it—register today: i3hevents.org

Have you registered for the Immune Health Hackathon (Nov. 20-21)? Over the course of 48 hours, participants will work in interdisciplinary teams to tackle pressing challenges in immunology research to win cash prizes. Open to all members of the Penn community. Learn more and register: i3hevents.org

Congratulations to Janis Burkhardt, PhD, on her appointment as Associate Dean for Postdoctoral Research Training and Director of Biomedical Postdoctoral Programs (BPP) at the University of Pennsylvania. Learn more about her experience and new role: https://bit.ly/48kFEeL

New @pennmedicine.bsky.social research identifies a potential targeted treatment for Sweet’s syndrome—a rare, painful skin disease—by breaking a cycle of rogue immune cells that drive inflammation. A discovery that could one day replace steroids. www.pennmedicine.org/news/mechani...

Early findings from @pennmedicine.bsky.social and @cincychildrens.bsky.social suggest a new vaccine may prevent allergens from triggering harmful immune reactions and inflammation—"a potential breakthrough for millions of people worldwide who suffer from life-threatening allergies." spr.ly/6018AUcJO

Registration is open for the Immune Health Hackathon (Nov. 20-21)! Over the course of 48 hours, participants will work in interdisciplinary teams to tackle pressing challenges in immunology research! Open to all members of the Penn community. Register: i3hevents.org

At 3600 Civic Center Blvd, E. John Wherry, PhD welcomed Good Morning Philadelphia to Penn Medicine's new hub for hundreds of researchers in immune health, infectious disease, population health data sciences, and others engaged in cross-disciplinary collaboration. https://bit.ly/4mmwd1w

⏱️ Every minute in the United States, someone needs a blood transfusion because of their period. Penn’s Dr. Kathleen O’Neill is developing an mRNA therapy to treat abnormal uterine bleeding and uncover its causes—a potential breakthrough for menstrual health and #mRNA technology. bit.ly/4n8rGkB

Healthy blood cells can live without ARHGAP45—but acute myeloid leukemia cells can’t. 🩸 Junwei Shi, PhD (Associate Professor of Cancer Biology) and team show a CAR T + CDC42 inhibition strategy could target AML with minimal side effects. bit.ly/45OyXQu

Stay connected with us beyond Bluesky 👋 Follow the Institute for Immunology and Immune Health (I3H) on LinkedIn for deep dives into Penn’s groundbreaking #immunology research and the future of #ImmuneHealth.

www.linkedin.com/company/penn...